Drug
Axicabtagene Ciloleucel
Axicabtagene Ciloleucel: highest development phase Phase 2, developed by Kite, A Gilead Company. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Kite, A Gilead Company
Trials
| Drug | Phase | Indication |
|---|---|---|
| Axicabtagene Ciloleucel NCT05459571 | Phase 2 | Relapsed or Refractory Large B-cell Lymphoma |
Latest
No recent events.
Follow Axicabtagene Ciloleucel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.